Cardiotronic - Osypka Medical, Inc.

What Cardiotronic - Osypka Medical, Inc. does

Osypka Medical GmbH is a Berlin-headquartered, privately held medical device company founded in 1986 by Dr. Peter Osypka together with a group of biomedical engineers. The firm designs, manufactures, and distributes cardiac care devices organized into three product lines: (i) non-invasive hemodynamic monitoring under the Electrical Cardiometry™ ('Window to the Circulation®') franchise, anchored by the ICON® and ICONCORE® monitors and EC™-sensors; (ii) external temporary cardiac pacemakers (PACE® Model 101, 203, 300, branded 'Window to the Heart®') with companion disposable myocardial electrodes (MyoStim®), transvenous pacing leads (EndoStim®), and cables/adapters (StimConnect®); and (iii) the CORASIM® heart simulator for training. The proprietary Electrical Cardiometry™ technology uses electrical measurements to deliver continuous non-invasive cardiovascular assessment as an alternative to invasive catheter-based monitoring.

The company monetizes through hardware sales of monitoring and pacemaker systems and a recurring consumables stream from sensors and pacing disposables, supplemented by paid medical education delivered via the Osypka Meducate® platform (ECTM and PACING certification tracks). It reaches global customers primarily through a network of authorized distributors that handle local regulatory compliance, sales, and first-line technical support, with direct demand-generation layered through medical conferences, scientific symposia, a trilingual corporate website (English, Spanish, German), and a clinical evidence library that includes dedicated COVID-19 and critical-care research.

Customers are acute care hospitals, cardiac care units, intensive care units, and critical care settings that require non-invasive hemodynamic assessment or temporary pacing therapy. The company positions its value proposition around eliminating the infection and procedural risks of invasive cardiac output measurement and providing immediate temporary pacing for bradyarrhythmia and post-surgical management. No parent company, institutional investors, or external funding rounds are disclosed in the available source material, and the company operates as an independent, founder-influenced private GmbH.

Name

Cardiotronic - Osypka Medical, Inc.

Legal name

OSYPKA MEDICAL GmbH

Website

https://cardiotronic.net

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

1–10 employees

Short description

Osypka Medical GmbH, founded in 1986 in Berlin, Germany, develops and manufactures non-invasive hemodynamic monitoring devices (Electrical Cardiometry™) and external temporary cardiac pacemakers for hospitals, ICUs, and critical care settings, distributed globally through authorized distributors.

Ownership category

akta.pro rank

Product category

Cardiac Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industries

Cardiac Rhythm Management (Pacemakers, ICDs, CRT) (HLAHAFAC), Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

Keywords

• Non-invasive hemodynamic monitoring
• Temporary cardiac pacing
• Cardiac monitoring devices
• Electrical cardiometry technology
• External pacemakers

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel

Revenue model

1. Medical Device Sales: Revenue generated from the sale of medical devices including Electrical Cardiometry monitoring systems (ICON®, ICONCORE®), temporary cardiac pacemakers (PACE® series), and associated accessories (MyoStim®, EndoStim®, StimConnect®). Hardware-based revenue model with recurring disposable products.
2. Medical Education Services: Revenue from Osypka Meducate® education programs providing clinical training on Electrical Cardiometry and cardiac pacing technology. Includes both self-service online training and structured certification programs (ECTM and Pacing tracks).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Osypka Medical designs, manufactures, and sells non-invasive hemodynamic monitoring devices based on its proprietary Electrical Cardiometry™ (EC™) technology and external temporary cardiac pacemakers for hospitals, cardiac care units, and intensive care settings. Its portfolio includes the ICON® and ICONCORE® monitoring systems, the PACE® Models 101, 203, and 300 pacemakers, disposable leads and cables (MyoStim®, EndoStim®, StimConnect®), and the CORASIM® heart simulator for clinical training.

Product overview

Osypka Medical offers a portfolio of medical devices organized into three main product lines: Electrical Cardiometry™ and Temporary Cardiac Pacing as core products, supplemented by a heart simulator. The Electrical Cardiometry line includes ICON® and ICONCORE® monitoring devices with EC™-Sensors for non-invasive hemodynamic monitoring. The Temporary Cardiac Pacing line comprises PACE® Models 101, 203, and 300 external pacemakers, accompanied by disposable accessories including MyoStim® (temporary myocardial electrodes), EndoStim® (temporary pacing leads), and StimConnect® (cables and adapters). The CORASIM® heart simulator serves training and educational needs. The company was founded in 1986 and is headquartered in Berlin, Germany.

Differentiator

Problem solved

Functional benefit

Brands

• Electrical Cardiometry™: Non-invasive hemodynamic monitoring technology for continuous cardiovascular system monitoring.
• ICON®
• ICONCORE®
• PACE®
• MyoStim®
• EndoStim®
• StimConnect®
• CORASIM®
• Osypka Meducate®

Products and services

• ICON® Non-invasive hemodynamic monitoring device within the Electrical Cardiometry portfolio used by hospitals, ICUs, and clinical settings for continuous cardiovascular system assessment.
• ICONCORE® Core monitoring device in the Electrical Cardiometry product line used for non-invasive cardiovascular assessment in clinical settings.
• PACE MODEL 101 Temporary external cardiac pacemaker for pacing therapy and intrinsic heart rhythm assessment in hospitals and cardiac care settings.
• PACE® MODEL 203 Temporary external cardiac pacemaker for pacing therapy and intrinsic heart rhythm assessment in hospitals and cardiac care settings.
• PACE MODEL 300 Temporary external cardiac pacemaker for pacing therapy and intrinsic heart rhythm assessment in hospitals and cardiac care settings.
• MyoStim® Temporary myocardial electrodes used as disposables in cardiac pacing procedures alongside PACE® pacemakers.
• EndoStim® Temporary transvenous pacing leads used as disposables in cardiac stimulation procedures alongside PACE® pacemakers.
• StimConnect® Cables and adapters used as disposables for temporary cardiac pacing systems to connect leads and electrodes to PACE® pacemakers.
• CORASIM® Heart simulator used for training and educational purposes in cardiac care, supporting clinical proficiency with cardiac pacing technology.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Global Distributor NetworkcoreChannel Partner/ Reseller/ DistributorOsypka Medical operates through a network of authorized distributors covering international markets. Distributors are responsible for local market sales, regulatory compliance, and customer support. The company maintains a distributor locator page on its website.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• LiDCO Group: LiDCO provides minimally invasive cardiac output monitoring using lithium dilution — a comparable non-invasive/minimally-invasive hemodynamic alternative targeting the same perioperative and ICU customer base as EC™.
• Baxter International (Cheetah Medical / Starling SV): Baxter acquired Cheetah Medical, whose Starling SV uses bioimpedance-based non-invasive stroke volume variation monitoring — the closest direct competitor to Osypka's Electrical Cardiometry technology in hemodynamic monitoring.

Broad incumbents

• Medtronic: Medtronic is a global leader in cardiac rhythm management including temporary pacing — competing with Osypka's PACE® line in the procedural pacing segment and offering broader portfolio leverage.
• GE HealthCare: GE HealthCare's patient monitoring portfolio (CARESCAPE, ICU monitors) supports hemodynamic measurement and integrates with third-party sensors — competing in the same enterprise ICU procurement decisions as EC™.
• Edwards Lifesciences: Edwards offers FloTrac/Vigileo and HemoSphere as minimally invasive hemodynamic monitoring platforms widely used in OR/ICU — competing with EC™ for the same clinical workflow and budget.
• Getinge (PiCCO / PULSION): Getinge's PiCCO technology provides continuous hemodynamic monitoring via thermodilution; overlaps directly with EC™ in ICU critical care use cases.
• Abbott (St. Jude Medical): Abbott's cardiac rhythm management portfolio includes temporary external pacemakers and full CRM franchise — directly competes with PACE® while offering complementary monitoring solutions that overlap with EC™ workflows.
• Nihon Kohden: Nihon Kohden provides patient monitoring and cardiology solutions including impedance cardiography-based hemodynamic monitoring — overlapping with EC™ in patient monitoring and ECG/Hemodynamic workflows.
• Philips (IntelliVue / Hemodynamic Monitoring): Philips IntelliVue patient monitors incorporate hemodynamic parameters and integrate with multiple cardiac output technologies — competing for the same ICU bedside monitoring budget and clinical workflow.

Emerging players

• Biotronik: Biotronik develops pacemakers and CRM devices including temporary pacing solutions — a focused competitor in the pacing category where Osypka's PACE® line competes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cardiotronic-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiotronic - Osypka Medical, Inc.